| ¿µ¹® | parenteral administration of drugs | ÇÑ±Û | ºñ°æ±¸Àû ¾àǰÅõ¿© |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ÅëÇÏÁö ¾Ê´Â ´Ù¾çÇÑ ¾àǰÅõ¿© ¹æ¹ýÀ» ¸»ÇÔ. ÁÖ»ç±â¸¦ ÀÌ¿ëÇÑ´Ù. 1)ÇÇÇÏÁÖ»ç: subcutaneous injection-ÇǺΠ¹ØÀ¸·Î ÁÖ»çÇÏ´Â °Í. ´ë°³ ÆÈÀÇ Áß°£ºÎ¿¡ ÁÖ»çÇÑ´Ù. 2)ÁøÇdz»ÁÖ»ç: intradermal injection-¾ã°Ô Âñ·¯¼ ÁøÇdz»¿¡ ÁÖ»çÇÑ´Ù. ÁÖ·Î ¾Ë·¯Áö ȯÀÚÀÇ Ç׿ø°Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 3)±ÙÀ°³»ÁÖ»ç: intramuscular injection-À§ÆÈÀ̳ª, ȤÀº ¾ûµ¢ÀÌ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. À̰ÍÀº ÁÖ·Î ÇǺο¡ ÀÚ±ØÀÌ ½ÉÇÑ ¾àÁ¦³ª ȤÀº õõÈ÷ ÀÛ¿ëÇÏ´Â ¾àÁ¦¸¦ ¸¹ÀÌ ÁÖ»çÇÒ ¶§ »ç¿ëÇÑ´Ù. 4)Ç÷°üÁÖ»ç: intravenous(IV) injection-Á¤¸ÆÀ» ÅëÇØ ÁÖ»çÇÑ´Ù. ¾î´À Á¤¸ÆÀ̳ª °¡´ÉÇÏÁö¸¸, ´ë°³ ÆÈ¶ÒÀ̳ª ¹ß µîÀÇ Á¤¸ÆÀ» ÀÌ¿ëÇÑ´Ù. ºü¸¥ Ä¡·áÈ¿°ú¸¦ º¸±â À§ÇØ »ç¿ëÇÑ´Ù. À̶§ ÇǺο¡ ÀÚ±ØÀ» ÁÖ´Â ¾àÁ¦À̸é, »õÁö ¾Êµµ·Ï Á¶½ÉÇØ¾ß ÇÑ´Ù. 5) ¼ö¸·°³»ÁÖ»ç: intrathecal injection-µÎ°³³ª ô¼ö°³»¿¡ ÁÖ»çÇÒ ¶§ ÀÌ¿ëÇÑ´Ù. 6)°³»ÁÖ»ç: intracavitary injection-°ø°£À¸·Î µÈ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. ¿¹¸¦ µé¾î º¹ºÎ°ø°£À̳ª Èä°³»¿¡ ÁÖ»çÇÏ¿© »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | rectal administration of drugs | ÇÑ±Û | ¾à¹°ÀÇ °ðâÀÚÁ¾à½Ä Åõ¿© |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ÅëÇØ ¸ÔÀº ¾à¹°Àº Èí¼öµÈ ÈÄ °£À» °ÅÃÄ º´º¯ºÎÀ§·Î ¿î¹ÝµÈ´Ù. µû¶ó¼ °£¿¡¼ ´ë»ç°¡ µÇ¾î ¾à¹°·Î¼ÀÇ È¿°ú°¡ ¾ø¾îÁú °¡´É¼ºÀÌ ÀÖÀ» »Ó ¾Æ´Ï¶ó °£¿¡ µ¶¼ºÀÛ¿ëÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ÀÌ·¯ÇÑ ´ÜÁ¡À» º¸¿ÏÇϱâÀ§ÇØ °£À» ÅëÇÏÁö ¾Ê°í À绡¸® Èí¼öµÇ¾î º´º¯À¸·Î °¥ ¼ö ÀÖ´Â ¹æÆíÀ¸·Î Á÷ÀåÁ¾àÀ» »ç¿ëÇÑ´Ù. Á÷ÀåÀÇ Á¤¸ÆÈ帧Àº °£À» °ÅÄ¡Áö ¾Ê°í Á÷Á¢ ÇÏ´ëÁ¤¸ÆÀ» ÅëÇØ ¿ì½É¹æÀ¸·Î Èê·¯µé±â ¶§¹®ÀÌ´Ù. |
||
| ¿µ¹® | side effects of drugs | ÇÑ±Û | ¾à¹°ÀÇ ºÎÀÛ¿ë |
|---|---|---|---|
| ¼³¸í | ¾àÀ» »ç¿ëÇÒ ¶§ ±â´ëÇÏ´Â È¿°ú ¿Ü¿¡ ´Ù¸¥ Àå±â¿¡¼ ³ªÅ¸³ª´Â ¿øÄ¡ ¾Ê´Â È¿°ú¸¦ ÃÑĪÇÏ´Â ¸»ÀÌ´Ù. ¿¹¸¦ µé¾î Ç÷¾ÐÀ» ³·Ãß±â À§ÇØ Ç×°íÇ÷¾ÐÁ¦¸¦ »ç¿ë ½Ã, Ç÷¾ÐÀÌ ¶³¾îÁö´Â µ¿½Ã¿¡ ±â°üÁöÀÇ ¼öÃàÀÌ ÀϾ´Â Çö»ó. |
||
| ON | occipitonuchal; office nurse; onlay; optic nerve; orthopedic nurse; osteonecrosis; osteonectin; over... |
|---|---|
| SONH | spontaneous osteonecrosis of the hip |
| SONK | spontaneous osteonecrosis of the knee |
| d/t | due to |
| dt | due to; dystonic |
| DUE | DNA unwinding element |
|---|---|
| DUE | Drug usage evaluation |
| ON | Osteonecrosis |
| ONFH | osteonecrosis of the femoral head |
| ATD | Antithyroid drugs |
| osteonecrosis | Condition resulting from poor blood supply to an area of bone causing bone death. For more information on this condition, please see the medicinenet site on osteonecrosis. (12 Dec 1998) |
|---|---|
| due date | The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC). (12 Dec 1998) |
| dystonia, focal, due to blepharospasm | The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal. (12 Dec 1998) |
| dystonia, focal, due to torticollis | Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward. (12 Dec 1998) |
| thrombotic disease due to protein c deficiency | Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal. (12 Dec 1998) |
| veterinary drugs | Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products. (12 Dec 1998) |
| cytotoxic drugs | <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells. See: chemotherapy. (13 Nov 1997) |
| psychotropic drugs | A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents). (12 Dec 1998) |
| neuroleptic drugs | Literally nerve seising: used of chlorpromazine like drugs. Antagonise the effects of dopamine. Origin: Gr. Lepsis = a taking hold (18 Nov 1997) |
| street drugs | Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity. (12 Dec 1998) |
| designer drugs | Drugs designed and synthesised, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are mptp (a reverse ester of meperidine), mda (3,4-methylenedioxyamphetamine), and mdma (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines. (12 Dec 1998) |
| drugs, chinese herbal | Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesised compounds manufactured in china. (12 Dec 1998) |
| drugs, essential | Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3) (12 Dec 1998) |
| drugs, generic | Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies. (12 Dec 1998) |
| drugs, investigational | Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|